Hypercalcemia may develop both spontaneously and as a result of androgen therapy in women with disseminated breast carcinoma. If it develops while on this agent, the drug should be discontinued. Caution is required in administering these agents to patients with cardiac, renal or hepatic disease. Cholestatic jaundice is associated with therapeutic use of anabolic and androgenic steroids. Edema may occur occasionally with or without congestive heart failure. Concomitant administration of adrenal steroids or ACTH may add to the edema. In children, anabolic steroid treatment may accelerate bone maturation without producing compensatory gain in linear growth. This adverse effect may result in compromised adult stature. The younger the child the greater the risk of compromising final mature height. The effect on bone maturation should be monitored by assessing bone age of the wrist and hand every six months. This drug has not been shown to be safe and effective for the enhancement of athletic performance. Because of the potential risk of serious adverse health effects, this drug should not be used for such purpose.
Another positive effect of deca-durabolin was reported by many bodybuilders who prior using this drug experienced pains in joints but once using it they started to enjoy training with no pain and that is attributed to deca’s ability to store more water in connective tissues.
However there are some moments which must be known by you before you start using nandrolone decanoate , it has a very strong effect on decreasing your sexual drive and it can cause gyno in some individuals. So have Nolvadex (tamoxifen citrate) on hand in case you feel gyno symptoms.